DE3571833D1 - Immunoassay for breast cancer employing monoclonal antibodies - Google Patents

Immunoassay for breast cancer employing monoclonal antibodies

Info

Publication number
DE3571833D1
DE3571833D1 DE8585110575T DE3571833T DE3571833D1 DE 3571833 D1 DE3571833 D1 DE 3571833D1 DE 8585110575 T DE8585110575 T DE 8585110575T DE 3571833 T DE3571833 T DE 3571833T DE 3571833 D1 DE3571833 D1 DE 3571833D1
Authority
DE
Germany
Prior art keywords
immunoassay
breast cancer
monoclonal antibodies
employing monoclonal
cancer employing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585110575T
Other languages
English (en)
Inventor
Iafa Keydar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Tel Aviv University
Original Assignee
Teva Pharmaceutical Industries Ltd
Tel Aviv University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd, Tel Aviv University filed Critical Teva Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of DE3571833D1 publication Critical patent/DE3571833D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/971—Capture of complex after antigen-antibody reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8585110575T 1984-08-22 1985-08-22 Immunoassay for breast cancer employing monoclonal antibodies Expired DE3571833D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64327984A 1984-08-22 1984-08-22
US06/702,055 US4707438A (en) 1984-08-22 1985-02-15 Immunoassay for breast cancer employing monoclonal antibodies

Publications (1)

Publication Number Publication Date
DE3571833D1 true DE3571833D1 (en) 1989-08-31

Family

ID=27094224

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585110575T Expired DE3571833D1 (en) 1984-08-22 1985-08-22 Immunoassay for breast cancer employing monoclonal antibodies

Country Status (5)

Country Link
US (1) US4707438A (de)
EP (1) EP0174534B1 (de)
AU (1) AU588542B2 (de)
CA (1) CA1248471A (de)
DE (1) DE3571833D1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032521A (en) * 1984-12-05 1991-07-16 The Salk Institute For Biological Studies Monoclonal antibody specific for a mammary tumor cell surface antigen
US4938948A (en) * 1985-10-07 1990-07-03 Cetus Corporation Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
AU601379B2 (en) * 1985-11-07 1990-09-13 Trustees Of Columbia University In The City Of New York, The Antigen indicative of human breast cancer and assays based thereon
NZ222509A (en) * 1986-11-19 1993-03-26 Oncogen Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
US6054438A (en) * 1987-01-07 2000-04-25 Imperial Cancer Research Technology Limited Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin
GB8702816D0 (en) * 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5013645A (en) * 1987-04-14 1991-05-07 Abbott Laboratories Immunological methods and materials for detection of tumor associated antigens
AU2253688A (en) * 1987-07-24 1989-03-01 Xoma Corporation Methods for breast cancer detection
US6287793B1 (en) 1988-08-19 2001-09-11 Elan Pharmaceuticals, Inc. Diagnostic methods for alzheimer's disease
US5149634A (en) * 1989-04-14 1992-09-22 The University Of Maryland Bioassay for environmental quality
US5411868A (en) * 1989-10-24 1995-05-02 Board Of Regents, The University Of Texas System Diagnostic and premonitoring uses of a 65 kDa tumor-associated protein in companion and domestic animal malignancy
JP3423306B2 (ja) * 1989-11-03 2003-07-07 エル． モートン，ドナルド 尿中腫瘍関連抗原、抗原性サブユニットの使用および検出方法
US5036861A (en) * 1990-01-11 1991-08-06 Sembrowich Walter L Method and apparatus for non-invasively monitoring plasma glucose levels
FR2668064B1 (fr) * 1990-10-23 1994-12-16 Transgene Sa Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne.
DK0584343T3 (da) * 1992-03-10 1999-09-13 Jolla Cancer Res Found Rekombinant alkalisk phosphatase fra kalvetarme
US5424191A (en) * 1992-05-20 1995-06-13 The United States Of America As Represented By The Department Of Health And Human Services Epithelial cell specific differentiation marker
ATE280180T1 (de) * 1992-08-31 2004-11-15 Ludwig Inst Cancer Res Vom mage-3-gen abgeleitetes und von hla-a1 präsentiertes, isoliertes nonapeptid und dessen anwendungen
US5686247A (en) * 1995-11-09 1997-11-11 Mount Sinai School Of Medicine Of The City University Of New York Detection of mammary tumor virus env gene-like sequences in human breast cancer
US20050112622A1 (en) 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
EP1765263B1 (de) * 2004-07-14 2015-08-19 3M Deutschland GmbH Dentalzusammensetzung mit si-h-funktionalen carbosilan-komponenten
EP1765261B1 (de) * 2004-07-14 2015-08-19 3M Deutschland GmbH Dentalzusammensetzung mit ungesättigtes carbosilan enthaltenden bestandteilen
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
US20080200342A1 (en) 2007-02-15 2008-08-21 Rao Rupa S Device, Array, And Methods For Disease Detection And Analysis
CN115960226B (zh) * 2022-09-20 2023-06-16 北京科跃中楷生物技术有限公司 一种磁微粒免疫层析快速反应方法及检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL185309C (nl) * 1980-07-28 1990-03-01 Akzo Nv Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
EP0095502A4 (de) * 1981-12-08 1987-01-20 Univ South Carolina Menschliche monoklonale antikörper oder lymphokinen bei der abscheidung von zellen oder der diagnose von brustkrebs.
US4522918A (en) * 1981-12-15 1985-06-11 Jeffery Schlom Process for producing monoclonal antibodies reactive with human breast cancer
US4613576A (en) * 1983-03-09 1986-09-23 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cancer cells
AU534733B3 (en) * 1983-11-25 1984-03-22 University Of Melbourne, The Method of detecting breast cancer
AU571287B2 (en) * 1983-11-25 1988-04-14 University Of Melbourne, The Cell line and monoclonal antibody

Also Published As

Publication number Publication date
US4707438A (en) 1987-11-17
CA1248471A (en) 1989-01-10
AU4649585A (en) 1986-02-27
EP0174534B1 (de) 1989-07-26
EP0174534A1 (de) 1986-03-19
AU588542B2 (en) 1989-09-21

Similar Documents

Publication Publication Date Title
DE3571833D1 (en) Immunoassay for breast cancer employing monoclonal antibodies
GB8316001D0 (en) Monoclonal antibodies
EP0160446A3 (en) Breast tumor-associated antigen and monoclonal antibodies specific thereto
GB8426467D0 (en) Monoclonal antibodies
GB8426463D0 (en) Monoclonal antibodies
GB8422650D0 (en) Monoclonal antibodies
GB8422653D0 (en) Monoclonal antibodies
GB2146351B (en) Monoclonal antibody
GB2163178B (en) Novel monoclonal antibody
ZA85681B (en) Monoclonal antibody
GB8330331D0 (en) Monoclonal antibody
EP0180413A3 (en) Anti-human cancer monoclonal antibody
GB8426461D0 (en) Monoclonal antibodies
GB8426464D0 (en) Monoclonal antibodies
GB8422651D0 (en) Monoclonal antibodies
GB8422649D0 (en) Monoclonal antibodies
GB8426468D0 (en) Monoclonal antibodies
ZA856374B (en) Immunoassay for breast cancer employing monoclonal antibodies
GB8426459D0 (en) Monoclonal antibodies
GB8426470D0 (en) Monoclonal antibodies
GB8431171D0 (en) Monoclonal antibodies
GB8426469D0 (en) Monoclonal antibodies
GB8419456D0 (en) Monoclonal antibodies
GB8426465D0 (en) Monoclonal antibodies
GB8416845D0 (en) Monoclonal antibodies

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee